Product Description
SSAA09E2 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
SSAA09E2 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
Biovision | B2723 | SSAA09E2 DataSheet
Alternate Name/Synonyms: N-[[4-(4-Methyl-1-piperazinyl)phenyl]methyl]-5-isoxazolecarboxamide
Appearance: Crystalline solid
Formulation:
CAS Number: 883944-52-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₆H₂₀N₄O₂
Molecular Weight: 300.36
Cell-Permeable?: TRUE
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A novel inhibitor of SARS-CoV replication
MDL Number:
PubChem CID:
SMILES: CN1CCN(CC1)C2=CC=C(C=C2)CNC(=O)C3=CC=NO3
InChi: InChI=1S/C16H20N4O2/c1-19-8-10-20(11-9-19)14-4-2-13(3-5-14)12-17-16(21)15-6-7-18-22-15/h2-7H,8-12H2,1H3,(H,17,21)
InChi Key: OMRXBNSVRJWWAZ-UHFFFAOYSA-N